Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Retained Earnings (2023 - 2026)

BioAge Labs' Retained Earnings history spans 3 years, with the latest figure at -$333.4 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 136188.16% to -$333.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$333.4 million, a 136188.16% decrease, with the full-year FY2025 number at -$333.4 million, down 136188.16% from a year prior.
  • Retained Earnings hit -$333.4 million in Q4 2025 for BioAge Labs, down from $275000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for BIOA hit a ceiling of $275000.0 in Q3 2025 and a floor of -$333.4 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$152.5 million across 3 years, with a median of -$181.7 million in 2023.
  • The widest YoY moves for Retained Earnings: up 152.29% in 2025, down 136188.16% in 2025.
  • Tracing BIOA's Retained Earnings over 3 years: stood at -$181.7 million in 2023, then skyrocketed by 100.13% to $245000.0 in 2024, then tumbled by 136188.16% to -$333.4 million in 2025.
  • Business Quant data shows Retained Earnings for BIOA at -$333.4 million in Q4 2025, $275000.0 in Q3 2025, and -$287.3 million in Q2 2025.